Literature DB >> 408426

Antifungal activity of four tetracycline analogues against Candida albicans in vitro: potentiation by amphotericin B.

M A Lew, K M Beckett, M J Levin.   

Abstract

The antifungal activities of four tetracycline analogues in combination with amphotericin B (AmB) were determined against 20 strains of Candida albicans. When a microtiter checkerboard technique was used, minocycline (less than or equal to 10 microgram/ml) acted synergistically with AmB against all strains, whereas doxycycline had a reduced effect, and demeclocycline and tetracycline had no potentiating effect at this concentration. Killing-curve experiments with two strains of C. albicans demonstrated that the combination of minocycline and AmB produced a decrease in number of colony-forming units (cfu) of greater than 2 logs in 4 hr and a 4-log decrease in cfu in 24 hr at concentrations (minocycline, 0.64 microgram/ml; AmB, 0.1 microgram/ml) that were subinhibitory when each agent was used alone and that are readily achieved in human serum and body fluids with conventional doses. The killing-curve technique indicated that doxycycline had an intermediate degree of synergistic activity, whereas tetracycline had no synergistic activity at clinically relevant concentrations.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 408426     DOI: 10.1093/infdis/136.2.263

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  13 in total

1.  Potentiation of antifungal activity of amphotericin B by azithromycin against Aspergillus species.

Authors:  M H Nguyen; C J Clancy; Y C Yu; A S Lewin
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1997-11       Impact factor: 3.267

2.  Improved Tet-On and Tet-Off systems for tetracycline-regulated expression of genes in Candida.

Authors:  Swati Bijlani; Anubhav S Nahar; K Ganesan
Journal:  Curr Genet       Date:  2017-06-08       Impact factor: 3.886

3.  In vitro analysis of flufenamic acid activity against Candida albicans biofilms.

Authors:  Alba A Chavez-Dozal; Maximillian Jahng; Hallie S Rane; Kingsley Asare; Vibhati V Kulkarny; Stella M Bernardo; Samuel A Lee
Journal:  Int J Antimicrob Agents       Date:  2013-10-01       Impact factor: 5.283

4.  In vitro susceptibility of Pythium insidiosum to macrolides and tetracycline antibiotics.

Authors:  Erico Silva Loreto; Débora Alves Nunes Mario; Laura Bedin Denardi; Sydney Hartz Alves; Janio Morais Santurio
Journal:  Antimicrob Agents Chemother       Date:  2011-05-02       Impact factor: 5.191

5.  Ureteral blockage by Candida in a patient with urinary derivation type Camey.

Authors:  R G Aguilera; R R Aldosa; G Rius-Espina; J P López
Journal:  Int Urol Nephrol       Date:  1989       Impact factor: 2.370

6.  In vitro susceptibilities of Naegleria fowleri strain HB-1 to selected antimicrobial agents, singly and in combination.

Authors:  K K Lee; S L Karr; M M Wong; P D Hoeprich
Journal:  Antimicrob Agents Chemother       Date:  1979-08       Impact factor: 5.191

7.  Effect of ketoconazole on the fungicidal action of amphotericin B in Candida albicans.

Authors:  I J Sud; D S Feingold
Journal:  Antimicrob Agents Chemother       Date:  1983-01       Impact factor: 5.191

8.  Interactions among amphotericin B, 5-fluorocytosine, ketoconazole, and miconazole against pathogenic fungi in vitro.

Authors:  F C Odds
Journal:  Antimicrob Agents Chemother       Date:  1982-11       Impact factor: 5.191

9.  Activity of 2,4-diaminoquinazoline compounds against Candida species.

Authors:  R A Castaldo; D W Gump; J J McCormack
Journal:  Antimicrob Agents Chemother       Date:  1979-01       Impact factor: 5.191

10.  Enhancement of the in vitro activity of amphotericin B against Aspergillus spp. by tetracycline analogs.

Authors:  C E Hughes; C Harris; L R Peterson; D N Gerding
Journal:  Antimicrob Agents Chemother       Date:  1984-12       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.